3 Reasons Why Growth Investors Shouldn't Overlook Universal Health Services (UHS)
Werte in diesem Artikel
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task.By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.However, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.Universal Health Services (UHS) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank.Studies have shown that stocks with the best growth features consistently outperform the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.While there are numerous reasons why the stock of this hospital and health facility operator is a great growth pick right now, we have highlighted three of the most important factors below:Earnings GrowthEarnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.While the historical EPS growth rate for Universal Health Services is 5.7%, investors should actually focus on the projected growth. The company's EPS is expected to grow 14% this year, crushing the industry average, which calls for EPS growth of 13.8%.Impressive Asset Utilization RatioGrowth investors often overlook asset utilization ratio, also known as sales-to-total-assets (S/TA) ratio, but it is an important feature of a real growth stock. This metric exhibits how efficiently a firm is utilizing its assets to generate sales.Right now, Universal Health Services has an S/TA ratio of 1.11, which means that the company gets $1.11 in sales for each dollar in assets. Comparing this to the industry average of 0.89, it can be said that the company is more efficient.While the level of efficiency in generating sales matters a lot, so does the sales growth of a company. And Universal Health Services is well positioned from a sales growth perspective too. The company's sales are expected to grow 7.7% this year versus the industry average of 1.1%.Promising Earnings Estimate RevisionsSuperiority of a stock in terms of the metrics outlined above can be further validated by looking at the trend in earnings estimate revisions. A positive trend is of course favorable here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.The current-year earnings estimates for Universal Health Services have been revising upward. The Zacks Consensus Estimate for the current year has surged 3.2% over the past month.Bottom LineWhile the overall earnings estimate revisions have made Universal Health Services a Zacks Rank #1 stock, it has earned itself a Growth Score of A based on a number of factors, including the ones discussed above.You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.This combination positions Universal Health Services well for outperformance, so growth investors may want to bet on it.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Universal Health Services, Inc. (UHS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Universal Health Services und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Universal Health Services
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Universal Health Services
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Universal Health Services Inc.
Analysen zu Universal Health Services Inc.
Datum | Rating | Analyst | |
---|---|---|---|
03.01.2019 | Universal Health Services Buy | Deutsche Bank AG | |
20.10.2017 | Universal Health Services Outperform | BMO Capital Markets | |
27.04.2017 | Universal Health Services Outperform | RBC Capital Markets | |
05.04.2017 | Universal Health Services Buy | Deutsche Bank AG | |
27.03.2017 | Universal Health Services Buy | Mizuho |
Datum | Rating | Analyst | |
---|---|---|---|
03.01.2019 | Universal Health Services Buy | Deutsche Bank AG | |
20.10.2017 | Universal Health Services Outperform | BMO Capital Markets | |
27.04.2017 | Universal Health Services Outperform | RBC Capital Markets | |
05.04.2017 | Universal Health Services Buy | Deutsche Bank AG | |
27.03.2017 | Universal Health Services Buy | Mizuho |
Datum | Rating | Analyst | |
---|---|---|---|
27.02.2017 | Universal Health Services Neutral | Mizuho | |
09.11.2016 | Universal Health Services Neutral | Mizuho | |
21.04.2016 | Universal Health Services Hold | Standpoint Research | |
29.10.2015 | Universal Health Services Equal Weight | Barclays Capital | |
03.08.2015 | Universal Health Services Equal Weight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
20.02.2007 | Universal Health underperform | Bear Stearns | |
31.08.2005 | Update Universal Health Services Inc.: Underperfor | Goldman Sachs | |
31.08.2005 | Universal Health underperform | Goldman Sachs | |
24.01.2005 | Update Universal Health Services Inc.: Reduce | UBS |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Universal Health Services Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen